A study from the University of Pennsylvania's Perelman School of Medicine found more evidence that weight loss drugs could be ...
Morning Overview on MSN
Women taking Ozempic-style drugs were about 30% less likely to develop breast cancer, a large study found
A retrospective study of more than 110,000 women ages 45 to 80 found that those taking GLP-1 receptor agonist medications ...
Higher flavodiet scores were associated with lower breast cancer risk among 93,271 UK Biobank females followed for a median ...
There is a promising shift toward nonsurgical treatment strategies in early breast cancer, as clinicians aim to reduce harm ...
Brain metastases are a major challenge in HER2-positive metastatic breast cancer; epidemiologic series suggest that roughly 30%–50% of patients eventually develop brain involvement, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results